Radiation myelitis after durvalumab administration following chemoradiotherapy for locally advanced non-small cell lung cancer: an illustrative case report and review of the literature
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2192-3183
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Radiation myelitis after durvalumab administration following chemoradiotherapy for locally advanced non-small cell lung cancer: an illustrative case report and review of the literature ; day:13 ; month:3 ; year:2019 ; pages:1-4
International Cancer Conference journal ; (13.3.2019), 1-4
- Creator
-
Kubo, Katsumaro
Wadasaki, Koichi
Yamane, Hiroaki
Doi, Mihoko
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1007/s13691-019-00367-5
- URN
-
urn:nbn:de:101:1-2019040621115052738544
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Kubo, Katsumaro
- Wadasaki, Koichi
- Yamane, Hiroaki
- Doi, Mihoko
- SpringerLink (Online service)
Other Objects (12)
Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
Durvalumab Consolidation Treatment after Chemoradiotherapy for an HIV-Positive Patient with Locally Advanced Non-Small Cell Lung Cancer
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
Longitudinal extensive transverse myelitis after chemoradiation therapy with durvalumab, a rare complication: case report
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer
Preoperative chemoradiotherapy for locally advanced gastric cancer
Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer
Arzneimittel Profil Durvalumab
Über Myelitis und zwei Faelle von Myelitis acuta : Inaug. Diss.
Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
Durvalumab Consolidation Treatment after Chemoradiotherapy for an HIV-Positive Patient with Locally Advanced Non-Small Cell Lung Cancer
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
Longitudinal extensive transverse myelitis after chemoradiation therapy with durvalumab, a rare complication: case report
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer
Preoperative chemoradiotherapy for locally advanced gastric cancer
Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer
Arzneimittel Profil Durvalumab
Über Myelitis und zwei Faelle von Myelitis acuta : Inaug. Diss.
Paraneoplastic myelitis associated with durvalumab treatment for extensive-stage small cell lung cancer
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
Durvalumab Consolidation Treatment after Chemoradiotherapy for an HIV-Positive Patient with Locally Advanced Non-Small Cell Lung Cancer
Real-world prospective analysis of treatment patterns in durvalumab maintenance after chemoradiotherapy in unresectable, locally advanced NSCLC patients
Longitudinal extensive transverse myelitis after chemoradiation therapy with durvalumab, a rare complication: case report
Chemo-radiotherapy plus durvalumab for loco-regional relapse of resected NSCLC
Predicting factors of symptomatic radiation pneumonitis induced by durvalumab following concurrent chemoradiotherapy in locally advanced non-small cell lung cancer
Preoperative chemoradiotherapy for locally advanced gastric cancer
Durvalumab after chemoradiotherapy for locally advanced non-small cell lung cancer prolonged distant metastasis-free survival, progression-free survival and overall survival in clinical practice
Clinical outcomes of chemoradiotherapy for locally recurrent rectal cancer
Arzneimittel Profil Durvalumab